Kallistatin is a potent new vasodilator.
Kallistatin is a serine proteinase inhibitor which binds to tissue kallikrein and inhibits its activity. The aim of this study is to evaluate if kallistatin has a direct effect on the vasculature and on blood pressure homeostasis. We found that an intravenous bolus injection of human kallistatin cau...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1997
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC508159/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9202051/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI119502 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|